CTOs on the Move

Merit Medical Systems

www.merit.com

 
Merit Medical Systems, Inc is a leading manufacturer of medical devices used in diagnostic and interventional cardiology and radiology procedures. Its primary products consist of inflation devices used in angioplasty, stent placement and discography; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; guide wires used to place balloon angioplasty catheters within a patient`s coronary arteries; products used to manage and monitor the administration of contrast and other fluid solutions during diagnostic and therapeutic procedures; thrombolytic catheters and fluid dispensing systems; angiography accessories; and standard and custom angiography kits. Headquartered in South Jordan, Utah, a suburb of ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million
  • www.merit.com
  • 1600 W Merit Pkwy
    South Jordan, UT USA 84095
  • Phone: 801.253.1600

Executives

Name Title Contact Details
Kevin Bovee
VP, Global Quality Systems Profile
Ricardo Aguirre
VP Global Quality Operations Profile

Funding

Merit Medical Systems raised $217M on 07/31/2018

Similar Companies

Gartman Systems

Gartman Systems is a Sheridan, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neocis

Neocis is transforming dental implant surgery with advanced robotics. The company is focused on enhancing dental surgeons` capabilities and advancing patient care through the latest technology.

Oklahoma Occupational Therapy Association (OOTA)

Oklahoma Occupational Therapy Association (OOTA) is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Guidry and East

Guidry and East is a League City, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RenalGuard Solutions

Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.